| Name: | Aripiprazole EP Impurity E |
| Catalogue No. | VL197007 |
| CAS No. | 129722-25-4 |
| Molecular Formula | C23H25Cl2N3O2 |
| Molecular Weight | 446.37 |
| Status | In-stock |
| IUPAC Name | 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-2(1H)-Quinolinone |
| Synonyms | Aripiprazole Related Compound G / Dehydro Aripiprazole |
| Appearance | Light Yellow Powder |
| Description | Aripiprazole Related Compound G / Aripiprazole Impurity E / Dehydro Aripiprazole(CAS No: 129722-25-4)or 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-2(1H)-Quinolinone is an impurity of aripiprazole. it is a class of atypical antipsychotics that are used for the treatment of schizophrenia and schizoaffective disorder. it has a high affinity for dopamine D2 receptors. |
| References | Arıkan, Mehmet Kemal, et al. “Gamma Oscillations Predict Treatment Response to Aripiprazole in Bipolar Disorder.” Journal of Affective Disorders, vol. 294, Nov. 2021, pp. 159–62, https://doi.org/10.1016/j.jad.2021.07.044. Mace, Shubhra, and David Taylor. “Aripiprazole.” CNS Drugs, vol. 23, no. 9, Sept. 2009, pp. 773–80, https://doi.org/10.2165/11310820-000000000-00000. |
![Aripiprazole(N-3-(hydroxyphenyl)-3[(2-oxo-1H-quinoline-7-yl)oxy]propanamide)](/public/site/files/site_images/thumb_aripiprazole-n-3-hydroxyphenyl-3-2-oxo-1h-quinoline-7-yl-oxy-propanamide64113.png)
![Di-[2-(2,3-dichlorophenyl)aminoethyl]amine](/public/site/files/site_images/thumb_di-2-2-3-dichlorophenyl-aminoethyl-amine73090.png)
